Company news

Oramed Pharmaceuticals Inc. news in 2022

Oramed Pharmaceuticals Inc.'s news releases, calls and decks from 2022, newest first.

View company

Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism

November 28, 2022

MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea

November 17, 2022

Oramed Announces Additional Positive Safety and Efficacy Data from Its Phase 2 Clinical Trial of ORMD-0801 for NASH

November 16, 2022

Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea

November 13, 2022

Oramed Reports Third Quarter 2022 Financial Results

November 9, 2022

Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH

November 8, 2022

Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine

October 6, 2022

Oramed Reports Positive Top-Line Results from Phase 2 NASH Trial with its ORMD-0801, Oral Insulin Candidate

September 12, 2022

Oramed to Present at H.C. Wainwright 24th Annual Global Investment Conference

September 5, 2022

Oramed Reaches 50% Enrollment in its Second Phase 3 Oral Insulin Trial

July 25, 2022

Oramed to Present at the Upcoming Canaccord Genuity Annual Growth Conference

July 10, 2022

Oramed Appoints Dr. Anne Peters to its Scientific Advisory Board

May 31, 2022

Oramed to Present at H.C. Wainwright Global Investment Conference

May 17, 2022

Oramed Completes Patient Enrollment in Pivotal Phase 3 Oral Insulin Study ORA-D-013-1

May 2, 2022

Oramed Granted NASH Patent in Europe

April 4, 2022

Oramed Appoints Yadin Rozov to its Board of Directors

April 3, 2022

Oramed's Diabetes Market Survey Shows Strong Interest for ORMD-0801 Oral Insulin Candidate Among Physicians

March 28, 2022

Oramed to Host Key Opinion Leader Webinar on Need for Oral Insulin in Type 2 Diabetes

March 21, 2022

Oramed Completes Patient Enrollment in Phase 2 Oral Insulin NASH Trial

March 15, 2022

Oramed to Present at Barclays Global Healthcare Conference

March 9, 2022

Oramed Issues Annual Message to Shareholders

January 11, 2022

Oramed Granted Key European Patent for Platform Technology in Oral Delivery of Proteins

January 4, 2022

Decks in 2022